Antifibrinolytic
WikiDoc Resources for Antifibrinolytic |
Articles |
---|
Most recent articles on Antifibrinolytic Most cited articles on Antifibrinolytic |
Media |
Powerpoint slides on Antifibrinolytic |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Antifibrinolytic at Clinical Trials.gov Trial results on Antifibrinolytic Clinical Trials on Antifibrinolytic at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Antifibrinolytic NICE Guidance on Antifibrinolytic
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Antifibrinolytic Discussion groups on Antifibrinolytic Patient Handouts on Antifibrinolytic Directions to Hospitals Treating Antifibrinolytic Risk calculators and risk factors for Antifibrinolytic
|
Healthcare Provider Resources |
Causes & Risk Factors for Antifibrinolytic |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Antifibrinolytics, such as aminocaproic acid (ε-aminocaproic acid) and tranexamic acid are used as inhibitors of fibrinolysis, which act by blocking the lysine-binding site on plasmin.
They are used in menorrhagia and bleeding tendency due to various causes.
External links
- Antifibrinolytics at the US National Library of Medicine Medical Subject Headings (MeSH)
- Template:MeshPharmaList